All results
1 results for phase 3 multicenter open label randomized study nab paclitaxel plus gemcitabine
-
Study of CTX-009 in Combo w/ Paclitaxel in Pts w/ Unresectable Advanced, Metastatic, Recurrent BTC
This is a multi-center, open-label, randomized, phase 2/3 trial of the bispecific antibody CTX-009 plus paclitaxel versus paclitaxel in patients with…
- Ages
- 18 Years - N/A
- Sexes
- All